These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36591517)

  • 1. Whole exome sequencing in Chinese mucinous pulmonary adenocarcinoma uncovers specific genetic variations different from lung adenocarcinoma.
    Zhang C; Wang K; Liu W; Lin J; Li Z; Wang H; Zhao C; Chen Y; Wu S; Yang A; Wu J; Wang H
    Front Oncol; 2022; 12():1054845. PubMed ID: 36591517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study.
    Shi J; Hua X; Zhu B; Ravichandran S; Wang M; Nguyen C; Brodie SA; Palleschi A; Alloisio M; Pariscenti G; Jones K; Zhou W; Bouk AJ; Boland J; Hicks B; Risch A; Bennett H; Luke BT; Song L; Duan J; Liu P; Kohno T; Chen Q; Meerzaman D; Marconett C; Laird-Offringa I; Mills I; Caporaso NE; Gail MH; Pesatori AC; Consonni D; Bertazzi PA; Chanock SJ; Landi MT
    PLoS Med; 2016 Dec; 13(12):e1002162. PubMed ID: 27923066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up.
    Kadara H; Choi M; Zhang J; Parra ER; Rodriguez-Canales J; Gaffney SG; Zhao Z; Behrens C; Fujimoto J; Chow C; Yoo Y; Kalhor N; Moran C; Rimm D; Swisher S; Gibbons DL; Heymach J; Kaftan E; Townsend JP; Lynch TJ; Schlessinger J; Lee J; Lifton RP; Wistuba II; Herbst RS
    Ann Oncol; 2017 Jan; 28(1):75-82. PubMed ID: 27687306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic landscape of ground glass opacities (GGOs) in East Asians.
    Cao P; Hu S; Kong K; Han P; Yue J; Deng Y; Zhao B; Li F
    J Thorac Dis; 2021 Apr; 13(4):2393-2403. PubMed ID: 34012587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic Landscape of RTK/RAS Pathway and Tumor Immune Infiltration as Prognostic Indicator of Lung Adenocarcinoma.
    Yin XQ; Yin XH; Yu YQ; Xu L; Zhang M
    Front Oncol; 2022; 12():924239. PubMed ID: 35936718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung.
    Shim HS; Kenudson M; Zheng Z; Liebers M; Cha YJ; Hoang Ho Q; Onozato M; Phi Le L; Heist RS; Iafrate AJ
    J Thorac Oncol; 2015 Aug; 10(8):1156-62. PubMed ID: 26200269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole exome sequencing (WES) analysis of transformed small cell lung cancer (SCLC) from lung adenocarcinoma (LUAD).
    Xie T; Li Y; Ying J; Cai W; Li J; Lee KY; Ricciuti B; Pacheco J; Xing P
    Transl Lung Cancer Res; 2020 Dec; 9(6):2428-2439. PubMed ID: 33489804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic Variations and Immune-Related Features of TMB, PD-L1 Expression and CD8
    Zhang C; Li Z; Zhang Y; Zhao C; Wang H; Lin J; Liu C; Wang X; Wang H
    Int J Gen Med; 2022; 15():4209-4220. PubMed ID: 35480996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Profiling and Prognostic Value Analysis of Genetic Alterations in Chinese Resected Lung Cancer With Invasive Mucinous Adenocarcinoma.
    Cai L; Wang J; Yan J; Zeng J; Zhu L; Liang J; Pan C; Huang X; Jin J; Xu Y; Wang F; Shao Y; Xu Q; Xia G; Xing M; Xu X; Jiang Y
    Front Oncol; 2020; 10():603671. PubMed ID: 33505917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analyses unveil novel genomic and immunological characteristics of micropapillary pattern in lung adenocarcinoma.
    Huo Y; Sun L; Yuan J; Zhang H; Zhang Z; Zhang L; Huang W; Sun X; Tang Z; Feng Y; Mo H; Yang Z; Zhang C; Yu Z; Yue D; Zhang B; Wang C
    Front Oncol; 2022; 12():931209. PubMed ID: 35992814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma.
    Zhang C; Zhang J; Xu FP; Wang YG; Xie Z; Su J; Dong S; Nie Q; Shao Y; Zhou Q; Yang JJ; Yang XN; Zhang XC; Li Z; Wu YL; Zhong WZ
    J Thorac Oncol; 2019 Nov; 14(11):1912-1923. PubMed ID: 31446140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic alterations dissection revealed
    Yuan C; Yao X; Dai P; Zhao Y; Sun Y
    Transl Lung Cancer Res; 2023 May; 12(5):985-998. PubMed ID: 37323170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic Mutations of Primary and Metastatic Lung Adenocarcinoma in Chinese Patients.
    Chen X; Bu Q; Yan X; Li Y; Yu Q; Zheng H; Zhao L; Zeng Y; Lu L; Lan D; Ma J
    J Oncol; 2020; 2020():6615575. PubMed ID: 33488709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparate genomic characteristics of patients with early-stage lung adenocarcinoma manifesting as radiological subsolid or solid lesions.
    Li H; Sun Z; Li Y; Qi Q; Huang H; Wang X; Zhou J; Liu K; Yin P; Wang Z; Li X; Yang F
    Lung Cancer; 2022 Apr; 166():178-188. PubMed ID: 35303645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-Exome Sequencing Reveals the Genomic Features of the Micropapillary Component in Ground-Glass Opacities.
    Meng F; Zhang Y; Wang S; Liu T; Sun M; Zhu H; Dong G; Xia Z; You J; Kong X; Wu J; Chen P; Yuan F; Yu X; Xu Y; Xu L; Yin R
    Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors.
    Pros E; Saigi M; Alameda D; Gomez-Mariano G; Martinez-Delgado B; Alburquerque-Bejar JJ; Carretero J; Tonda R; Esteve-Codina A; Catala I; Palmero R; Jove M; Lazaro C; Patiño-Garcia A; Gil-Bazo I; Verdura S; Teulé A; Torres-Lanzas J; Sidransky D; Reguart N; Pio R; Juan-Vidal O; Nadal E; Felip E; Montuenga LM; Sanchez-Cespedes M
    Ann Oncol; 2020 Feb; 31(2):274-282. PubMed ID: 31959344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic profiling of non-small cell lung cancer with the rare pulmonary lymphangitic carcinomatosis and clinical outcome of the exploratory anlotinib treatment.
    Dong C; Cheng W; Zhang M; Li S; Zhao L; Chen D; Qin Y; Xiao M; Fang S
    Front Oncol; 2022; 12():992596. PubMed ID: 36324591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique genomic features and prognostic value of COSMIC mutational signature 4 in lung adenocarcinoma and lung squamous cell carcinoma.
    Cai X; Chen Z; Deng M; Li Z; Wu Q; Wei J; Dai C; Wang G; Luo C
    Ann Transl Med; 2020 Sep; 8(18):1176. PubMed ID: 33241025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucinous adenocarcinoma of the colon and rectum: A genomic analysis.
    Reynolds IS; O'Connell E; Fichtner M; McNamara DA; Kay EW; Prehn JHM; Furney SJ; Burke JP
    J Surg Oncol; 2019 Dec; 120(8):1427-1435. PubMed ID: 31729037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular gene mutation profiles, TMB and the impact of prognosis in Caucasians and east Asian patients with lung adenocarcinoma.
    Gu W; Wang N; Gu W; Qiu Y; Zhang H; Liang J; Zhou T; Ma L; Cai W; Feng W; Chen L
    Transl Lung Cancer Res; 2020 Jun; 9(3):629-638. PubMed ID: 32676325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.